ADCT News
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure ImprovementsPR NewswireLAUSANNE, Switzerland, Oct. 8, 2026$86.6 Million...
PR Newswire
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure ImprovementsPR NewswireLAUSANNE, Switzerland, Oct. 8, 2026$86.6 Million...
PR Newswire
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference PR Newswire LAUSANNE, Switzerland, Sept. 3, 2026 LAUSANNE, Switzerland, Sept. 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT...
PR Newswire
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) {
.image-container {
width: 100% !important;
float: none !important;
margin: 0 0 1rem 0 !important;
}
}
Image source: The Mo...
Nasdaq News: Markets
ADC Therapeutics Q2 2026 Earnings Call Transcript
On Thursday, ADC Therapeutics (NYSE:ADCT) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financialread more...
Benzinga
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +42.11% and -4.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates PR Newswire LAUSANNE, Switzerland, Aug. 13, 2026 Second quarter 2026 net product revenue of $18.6 million...
PR Newswire
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of +35.29% and +13.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 PR Newswire LAUSANNE, Switzerland, Aug. 6, 2026 LAUSANNE, Switzerland, Aug. 6, 2026 /PRNewswire/ -- ADC...
PR Newswire
Alkermes (ALKS) Reports Break-Even Earnings for Q2
Alkermes (ALKS) delivered earnings and revenue surprises of +100.00% and +9.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
ADC Therapeutics Announces New Employee Inducement Grant
ADC Therapeutics Announces New Employee Inducement Grant ADC Therapeutics Announces New Employee Inducement Grant PR Newswire LAUSANNE, Switzerland, July 1, 2026 LAUSANNE, Switzerland, July 1, 2026 /PRNewswire/ --ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the...
PR Newswire